Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 8, 2025, after the close
10-Q filed May 8, 2025, 38 days after period end · 0000320017-25-000030
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — |
| Net Income | -$4.72M | -$5.40M | -$6.19M | -$4.23M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.55 |
| -$0.65 |
| -$0.77 |
| -$1.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
